Breaking News Instant updates and real-time market news.

MDRX

Allscripts

$9.34

-0.03 (-0.32%)

, CSLT

Castlight Health

$3.66

0.06 (1.67%)

11:55
04/18/19
04/18
11:55
04/18/19
11:55

William Blair healthcare IT analyst to hold a group luncheon

Healthcare IT Analyst Garro holds a group luncheon meeting in New York on April 18 at 12:30 pm hosted by William Blair.

MDRX

Allscripts

$9.34

-0.03 (-0.32%)

CSLT

Castlight Health

$3.66

0.06 (1.67%)

CERN

Cerner

$62.43

0.02 (0.03%)

CPSI

Computer Programs

$29.07

0.05 (0.17%)

FIT

Fitbit

$5.39

(0.00%)

NXGN

NextGen Healthcare

$16.83

0.07 (0.42%)

  • 18

    Apr

  • 25

    Apr

  • 29

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 05

    Jun

MDRX Allscripts
$9.34

-0.03 (-0.32%)

02/22/19
KEYB
02/22/19
DOWNGRADE
KEYB
Sector Weight
Allscripts downgraded to Sector Weight from Overweight at KeyBanc
02/22/19
SBSH
02/22/19
DOWNGRADE
Target $12
SBSH
Neutral
Allscripts downgraded to Neutral from Buy at Citi
Citi analyst Stephanie Demko downgraded Allscripts to Neutral and lowered her price target for the shares to $12 from $14. The "implied steepness" in the ramp to long-term guidance "may prove out of reach," while near-term challenges in investor sentiment could keep shares range bound, Demko tells investors in a post-earnings research note. She points out the stock traded down 11% as a miss on headline numbers and fiscal 2019 guidance "likely struck a raw nerve with investors" following management's bullish tone in January.
01/18/19
KEYB
01/18/19
UPGRADE
Target $15
KEYB
Overweight
Allscripts upgraded to Overweight from Sector Weight at KeyBanc
As previously reported, KeyBanc analyst Donald Hooker upgraded Allscripts to Overweight with a $15 price target following the company's divestiture of Netsmart. In a research note to investors, Hooker says he sees material upside in the company's share price if Allscripts can show any acceleration of growth in 2019 or 2020.
01/18/19
KEYB
01/18/19
UPGRADE
Target $15
KEYB
Overweight
Allscripts upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Donald Hooker upgraded Allscripts to Overweight with a $15 price target.
CSLT Castlight Health
$3.66

0.06 (1.67%)

10/18/18
WBLR
10/18/18
NO CHANGE
WBLR
Outperform
William Blair sees catalysts for Castlight shares after two-month selloff
William Blair analyst Jeffrey Garro points out that shares of Castlight Health (CSLT) have sold off steadily over the last two months following the announcement of Walmart's (WMT) nonrenewal in conjunction with weaker than expected bookings in the second quarter. The analyst, however, believes there is still support around the size of the market opportunity and the value generated by the company's healthcare navigation and well-being guidance platform for employers. Nonetheless, it will take better near-term execution before the company can reorient investors toward higher growth expectations and close the gap between its valuation and the peer group, Garro tells investors in a research note. He believes, though, that Castlight Health "may receive a pass" on the Walmart loss in time as more details emerge. Further, the looming general availability of Castlight Complete and achieving adjusted EBITDA profitability for the first time in Q4 can serve as near-term catalysts, Garro contends. He keeps an Outperform rating on the shares.
08/16/18
CANT
08/16/18
NO CHANGE
CANT
Overweight
Cantor Fitzgerald backs 'positive' view of healthcare IT segment
Cantor Fitzgerald Steven Halper tells investors in a research note that he is maintaining a positive investment view of the healthcare IT segment, and believes demand for products and services in the sector will continue to drive long-term growth. Specifically, he continues to rate Cerner (CERN) and Evolent Health (EVH) Overweight, as both are "nicely" leveraged to population health, with Evolent mostly a pure play in the segment. Within managed care, Halper believes Overweight-rated UnitedHealth (UNH) remains well-positioned with its Optum segment.
07/31/18
CANT
07/31/18
NO CHANGE
CANT
Castlight Health loss of Walmart overshadows Q2 beat, says Cantor
Castlight Health's (CSLT) beat in Q2 was overshadowed by the loss of large client Walmart (WMT) and the initiation of a cost-restructuring program to mitigate the loss of revenue in 2019, Cantor Fitzgerald analyst Steven Halper tells investors in a research note. Despite positive discussions recently, Walmart decided not to renew and migrate to Complete, the analyst adds. With 25% upside potential to his $5 price target, the analyst maintains an Overweight rating on Castlight amid the post-earnings selloff.
07/31/18
CHDN
07/31/18
DOWNGRADE
CHDN
Neutral
Castlight Health downgraded to Neutral from Buy at Chardan
CERN Cerner
$62.43

0.02 (0.03%)

04/10/19
RHCO
04/10/19
UPGRADE
RHCO
Buy
Cerner upgraded to Buy from Hold at SunTrust
04/10/19
RHCO
04/10/19
UPGRADE
Target $76
RHCO
Buy
Cerner upgraded to Buy from Hold at SunTrust
SunTrust analyst Sandy Draper upgraded Cerner to Buy and raised his price target to $76 from $60, saying the company's "margin pickup", expanded buyback, and cash flows will "yield positive results" for the stock. While the analyst expects a tough electronic health record end market to continue, he adds that the presence of an activist investor and the appointment of four new board members will give Cerner valuation a floor.
04/10/19
ADAM
04/10/19
NO CHANGE
Target $68
ADAM
Buy
Cerner board refreshment, other announcements encouraging, says Canaccord
Canaccord analyst Richard Close maintained a Buy rating and $68 price target on Cerner after the company announced plans to "refresh" its board, committed to improving margins and operations and increase share repurchases as part of a cooperation agreement with Starboard. In a research note to investors, Close says he is "encouraged" by the moves after previously commending the company in initiating a dividend, as the moves further solidify that management is focused on driving shareholder returns while delivering on commitments to existing and potential client partners.
04/10/19
SBSH
04/10/19
NO CHANGE
Target $77
SBSH
Buy
Cerner price target raised to $77 from $68 at Citi
Citi analyst Stephanie Demko raised her price target for Cerner to $77 from $68 and reiterates a Buy rating on the shares following the company's cooperation agreement with activist Starboard Value. The analyst believes Cerner is a "core HCIT asset with strong potential" in both margin expansion and capital returns.
CPSI Computer Programs
$29.07

0.05 (0.17%)

02/21/19
RHCO
02/21/19
NO CHANGE
Target $35
RHCO
Hold
Computer Programs price target raised to $35 from $30 at SunTrust
SunTrust analyst Sandy Draper raised his price target on Computer Programs to $35 after its Q4 earnings beat that he says was driven by lower costs. The analyst expects the company's "aggressive cost cuts to more than offset decreasing contributions from MU3" but also keeps his Hold rating considering the limited upside potential for the stock relative to his target.
02/15/19
PIPR
02/15/19
NO CHANGE
Target $35
PIPR
Neutral
Piper encouraged by Computer Programs bookings, still cautious on visibility
Following Computer Programs' reports of mixed Q4 results, Piper Jaffray analyst Sean Wieland said he encouraged to see strength in bookings and believes the fact that recurring revenue is growing as a portion of the business adds visibility. However, he remains cautious about the high variability and uncertainty in the company's model, noting that Computer Programs doesn't provide revenue and profitability guidance. He raised his price target on shares to $35 from $29, largely to account for a lower tax rate, but keeps a Neutral rating on the stock.
12/03/18
CANT
12/03/18
NO CHANGE
CANT
Cantor 'not too worried' about Amazon's healthcare IT initiative
Cantor Fitzgerald analyst Steven Halper is "not too worried" after Amazon (AMZN) last week confirmed plans to sell software that will mine patient medical records to reduce medical expenses. The analyst does not expect traditional electronic medical record vendors, including Allscripts (MDRX), Cerner (CERN), Computer Program and Systems (CPSI) and NextGen (NXGN) to be impacted by Amazon. It "remains to be seen whether Amazon's forays into the healthcare industry will be truly disruptive," says the analyst. He believes Amazon is likely positioning itself to benefit from pharmaceutical and medical supply sales.
08/03/18
PIPR
08/03/18
NO CHANGE
Target $29
PIPR
Neutral
Computer Programs price target lowered to $29 from $32 at Piper Jaffray
Piper Jaffray analyst Sean Wieland lowered his price target on Computer Programs to $29 after its Q2 earnings miss, saying the wide margin was attributed mainly to client delays in purchasing Meaningful Use required systems. The analyst notes that the management is confident in the second half recovery given the queue of pending implementations, but still sees risks of "very high stimulus incentive eligibility requirements, less than anticipated EHR adoption despite stimulus incentives, and competition". Wieland keeps his Neutral rating on Computer Programs.
FIT Fitbit
$5.39

(0.00%)

02/28/19
DADA
02/28/19
UPGRADE
DADA
Buy
Fitbit upgraded to Buy from Neutral at DA Davidson
02/28/19
DADA
02/28/19
UPGRADE
Target $7
DADA
Buy
Fitbit upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Tom Forte upgraded Fitbit to Buy and raised his price target to $7 from $5.50 after its Q4 results and outlook for Q1 and FY19. The analyst attributes the upgrade to his view of "improvements that the management has made to the company's operating results, including a return to both unit and sales growth." Forte is also positive on Fitbit's "attractive balance sheet" and the progress made in its healthcare services efforts, saying the risk/reward on the stock is favorable given the after-market decline in the share price.
02/28/19
02/28/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Fitbit (FIT) upgraded to Buy from Neutral at DA Davidson analyst Tom Forte citing Q4 results and outlook for Q1 and FY19. 2. Hain Celestial (HAIN) upgraded to Overweight from Neutral at JPMorgan with analyst Ken Goldman citing the company's "compelling" investor day, the analyst has increased confidence in Hain's ability to drive margin growth over the next few years. 3. Athene Holding (ATH) upgraded to Outperform from Market Perform at BMO Capital with analyst James Fotheringham saying the valuation multiple on the stock may have finally passed its trough at its current 5.5-times two-year forward earnings multiple and believes that its core business should be valued at 6.4-times. 4. Wabco (WBC) upgraded to Neutral from Underweight at JPMorgan and to Hold from Sell at Vertical Research. 5. Globus Medical (GMED) upgraded to Buy from Neutral at UBS with analyst Matthew Taylor saying the company has delivered several quarters in a row of improving spine growth, which confirms robot placements are leading to implant pull-through. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/19
DADA
04/05/19
NO CHANGE
Target $7
DADA
Buy
Fitbit's Snap partnership a positive, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $7 price target on Fitbit (FIT) after it announced a Bitmoji partnership with Snap (SNAP) that allows users to access Bitmoji avatars on the face of their Fitbit smartwatches. The analyst says the deal is a positive for Fitbit as it seeks to increase customer engagement and "make personal health more fun".
NXGN NextGen Healthcare
$16.83

0.07 (0.42%)

11/01/18
MSCO
11/01/18
UPGRADE
MSCO
Equal Weight
NextGen Healthcare upgraded to Equal Weight from Underweight at Morgan Stanley
11/01/18
11/01/18
UPGRADE
Target $16

Equal Weight
After consensus comes in, Morgan Stanley ups NextGen Healthcare to Equal Weight
As previously reported, Morgan Stanley analyst Ricky Goldwasser upgraded NextGen Healthcare to Equal Weight from Underweight, noting that revisions to consensus estimates following the company's quarterly report has made the Street view more aligned with his own view of how growth will be paced. While strong bookings provide improved mid-term visibility, the pace of growth is likely to be more measured than management projects, believes Goldwasser. He raised his price target on NextGen Healthcare shares to $16 from $12.
01/11/19
DOTC
01/11/19
UPGRADE
DOTC
Buy
NextGen Healthcare upgraded to Buy from Neutral at Dougherty

TODAY'S FREE FLY STORIES

EVH

Evolent Health

$8.60

-0.39 (-4.34%)

, ANTM

Anthem

$280.75

-2.84 (-1.00%)

13:48
12/11/19
12/11
13:48
12/11/19
13:48
Periodicals
Outgoing Kentucky administration upholds 'snub' of Evolent partner, LCJ says »

The finance secretary of…

EVH

Evolent Health

$8.60

-0.39 (-4.34%)

ANTM

Anthem

$280.75

-2.84 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAAS

Pan American Silver

$20.30

0.53 (2.68%)

13:45
12/11/19
12/11
13:45
12/11/19
13:45
Options
Pan American Silver call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
12/11/19
12/11
13:45
12/11/19
13:45
General news
Treasury Budget to be reported at 14:00 »

November Treasury Budget…

13:45
12/11/19
12/11
13:45
12/11/19
13:45
General news
FOMC Meeting Announcement Federal Funds Rate to be reported at 14:00 »

FOMC Meeting Announcement…

SBPH

Spring Bank Pharmaceuticals

$3.20

-0.25 (-7.25%)

13:41
12/11/19
12/11
13:41
12/11/19
13:41
Recommendations
Spring Bank Pharmaceuticals analyst commentary  »

Spring Bank to add CASOs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$13.99

-0.155 (-1.10%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Options
CenturyLink call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$34.68

0.39 (1.14%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
Cowen industrial innovation analyst to hold an analyst/industry conference call »

Industrial Innovation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

BIIB

Biogen

$293.60

-3.45 (-1.16%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
SVB Leerink biotech analyst to hold analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLNX

Xilinx

$93.24

1.99 (2.18%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
Xilinx participates in a conference call with Benchmark »

Semiconductor Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

  • 28

    Jan

DISCA

Discovery

$32.21

-0.03 (-0.09%)

, DISCK

Discovery Inc.

$29.98

-0.005 (-0.02%)

13:21
12/11/19
12/11
13:21
12/11/19
13:21
Periodicals
Bruin Sports explores sale of streaming provider Deltatre, Bloomberg says »

Bruin Sports Capital is…

DISCA

Discovery

$32.21

-0.03 (-0.09%)

DISCK

Discovery Inc.

$29.98

-0.005 (-0.02%)

DIS

Disney

$146.88

0.76 (0.52%)

AMZN

Amazon.com

$1,737.40

-1.75 (-0.10%)

CMCSA

Comcast

$42.17

-0.6 (-1.40%)

CMCSK

Comcast

$0.00

(0.00%)

TWTR

Twitter

$30.17

0.32 (1.07%)

NFLX

Netflix

$297.28

4.07 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

LQDT

Liquidity Services

$6.15

-0.27 (-4.21%)

13:21
12/11/19
12/11
13:21
12/11/19
13:21
Recommendations
Liquidity Services analyst commentary  »

Liquidity Services on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/11/19
12/11
13:17
12/11/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/11/19
12/11
13:16
12/11/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$28.28

0.28 (1.00%)

13:15
12/11/19
12/11
13:15
12/11/19
13:15
Options
Corning put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PNRG

PrimeEnergy

$153.00

-2 (-1.29%)

13:15
12/11/19
12/11
13:15
12/11/19
13:15
Hot Stocks
PrimeEnergy director Clint Hurt sells over $1.1M in company shares »

PrimeEnergy director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMBA

Ambarella

$54.84

2.33 (4.44%)

13:05
12/11/19
12/11
13:05
12/11/19
13:05
Options
Ambarella call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

FB

Facebook

$201.00

0.1 (0.05%)

, ICE

IntercontinentalExchange

$92.63

0.31 (0.34%)

12:56
12/11/19
12/11
12:56
12/11/19
12:56
Periodicals
Nasdaq on track to beat NYSE in IPOs for first time since 2012, WSJ says »

Companies are on pace to…

FB

Facebook

$201.00

0.1 (0.05%)

ICE

IntercontinentalExchange

$92.63

0.31 (0.34%)

NDAQ

Nasdaq

$104.36

-0.26 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

  • 06

    Feb

12:55
12/11/19
12/11
12:55
12/11/19
12:55
Conference/Events
UBS retail analysts to hold an analyst/industry conference call »

Retail Analysts…

SGEN

Seattle Genetics

$111.78

-2.19 (-1.92%)

12:53
12/11/19
12/11
12:53
12/11/19
12:53
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

TWTR

Twitter

$30.16

0.31 (1.04%)

, SQ

Square

$65.52

-0.3 (-0.46%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
On The Fly
#SocialStocks: YouTube updates harassment policy, Snapchat 'deepfake' GIFs »

Welcome to…

TWTR

Twitter

$30.16

0.31 (1.04%)

SQ

Square

$65.52

-0.3 (-0.46%)

FB

Facebook

$201.03

0.13 (0.06%)

AMZN

Amazon.com

$1,738.68

-0.47 (-0.03%)

SNAP

Snap

$14.15

0.065 (0.46%)

GOOGL

Alphabet Class A

$1,342.74

-0.3 (-0.02%)

GOOG

Alphabet

$1,344.23

-0.27 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 26

    Feb

CIEN

Ciena

$35.15

0.45 (1.30%)

, LOVE

Lovesac

$14.52

0.08 (0.55%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CIEN

Ciena

$35.15

0.45 (1.30%)

LOVE

Lovesac

$14.52

0.08 (0.55%)

VERU

Veru

$2.27

-0.03 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 17

    Dec

  • 19

    Dec

LULU

Lululemon

$232.23

2.67 (1.16%)

, NDSN

Nordson

$165.56

-0.19 (-0.11%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
Earnings
Notable companies reporting after market close »

Notable companies…

LULU

Lululemon

$232.23

2.67 (1.16%)

NDSN

Nordson

$165.56

-0.19 (-0.11%)

OXM

Oxford Industries

$74.50

-1.46 (-1.92%)

MESA

Mesa Air

$9.04

-0.04 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

CSCO

Cisco

$44.29

0.18 (0.41%)

, CMCSA

Comcast

$42.04

-0.73 (-1.71%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Hot Stocks
Cisco announces 'Internet for the Future' strategy »

Cisco (CSCO) unveiled…

CSCO

Cisco

$44.29

0.18 (0.41%)

CMCSA

Comcast

$42.04

-0.73 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 08

    Jan

  • 12

    Feb

ADI

Analog Devices

$115.90

1.48 (1.29%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Options
Analog Devices call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Hot Stocks
Gundlach says in next recession, U.S. will be worst stock market in world »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.